These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31714357)

  • 21. Neurodevelopment of breastfed HIV-exposed uninfected and HIV-unexposed children in South Africa.
    le Roux SM; Donald KA; Brittain K; Phillips TK; Zerbe A; Nguyen KK; Strandvik A; Kroon M; Abrams EJ; Myer L
    AIDS; 2018 Aug; 32(13):1781-1791. PubMed ID: 29794831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana.
    Chaudhury S; Mayondi GK; Williams PL; Leidner J; Shapiro R; Diseko M; Ajibola G; Holding P; Tepper V; Makhema J; Petlo C; Seage GR; Lockman S; Kammerer B
    AIDS; 2018 Jun; 32(9):1173-1183. PubMed ID: 29547434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of health programmes to prevent vertical transmission of HIV. Advances, emerging health challenges and research priorities for children exposed to or living with HIV: Perspectives from South Africa.
    Goga A; Slogrove A; Wedderburn CJ; Feucht U; Wessels J; Ramokolo V; Bhana A; Du Plessis N; Green RJ; Pillay Y; Sherman G
    S Afr Med J; 2019 Dec; 109(11b):77-82. PubMed ID: 32252873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country.
    Taron-Brocard C; Le Chenadec J; Faye A; Dollfus C; Goetghebuer T; Gajdos V; Labaune JM; Perilhou A; Mandelbrot L; Blanche S; Warszawski J;
    Clin Infect Dis; 2014 Nov; 59(9):1332-45. PubMed ID: 25053719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV infection, viral load, low birth weight, and nevirapine are independent influences on growth velocity in HIV-exposed South African infants.
    Ramokolo V; Lombard C; Fadnes LT; Doherty T; Jackson DJ; Goga AE; Chhagan M; Van den Broeck J
    J Nutr; 2014 Jan; 144(1):42-8. PubMed ID: 24198309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in Breast Milk Composition of HIV-Infected and HIV-Uninfected Mothers of Premature Infants: Effects of Antiretroviral Therapy.
    Fouché C; van Niekerk E; du Plessis LM
    Breastfeed Med; 2016 Nov; 11():455-460. PubMed ID: 27529566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.
    Kakkar F; Lamarre V; Ducruet T; Boucher M; Valois S; Soudeyns H; Lapointe N
    BMC Infect Dis; 2014 May; 14():236. PubMed ID: 24885498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants.
    Moonsamy S; Suchard M; Madhi SA
    PLoS One; 2019; 14(4):e0215079. PubMed ID: 31002702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants.
    Slogrove AL; Esser MM; Cotton MF; Speert DP; Kollmann TR; Singer J; Bettinger JA
    Pediatr Infect Dis J; 2017 Feb; 36(2):e38-e44. PubMed ID: 28081048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
    Prendergast A; Mphatswe W; Tudor-Williams G; Rakgotho M; Pillay V; Thobakgale C; McCarthy N; Morris L; Walker BD; Goulder P
    AIDS; 2008 Jul; 22(11):1333-43. PubMed ID: 18580613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 90-90-90 cascade analysis on reported CLHIV infected by mother-to-child transmission in Guangxi, China: a modeling study.
    Wang G; Lu C; Qin S; Wei W; Lai J; Jiang J; Liang B; Zhou O; Han J; Yang Y; Ye L; Liang H; Ning C
    Sci Rep; 2020 Mar; 10(1):5295. PubMed ID: 32210333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral therapy use during pregnancy and adverse birth outcomes in South African women.
    Malaba TR; Phillips T; Le Roux S; Brittain K; Zerbe A; Petro G; Ronan A; McIntyre JA; Abrams EJ; Myer L
    Int J Epidemiol; 2017 Oct; 46(5):1678-1689. PubMed ID: 29040569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South Africa.
    Springer PE; Slogrove AL; Kidd M; Kalk E; Bettinger JA; Esser MM; Cotton MF; Zunza M; Molteno CD; Kruger M
    AIDS Care; 2020 Apr; 32(4):411-419. PubMed ID: 31280587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
    Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal adherence to maternal antiretroviral therapy and infant Nevirapine prophylaxis from 6 weeks to 18 months postpartum amongst a cohort of mothers and infants in South Africa.
    Larsen A; Magasana V; Dinh TH; Ngandu N; Lombard C; Cheyip M; Ayalew K; Chirinda W; Kindra G; Jackson D; Goga A
    BMC Infect Dis; 2019 Sep; 19(Suppl 1):789. PubMed ID: 31526366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study.
    Wedderburn CJ; Yeung S; Rehman AM; Stadler JAM; Nhapi RT; Barnett W; Myer L; Gibb DM; Zar HJ; Stein DJ; Donald KA
    Lancet Child Adolesc Health; 2019 Nov; 3(11):803-813. PubMed ID: 31515160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral exposure during pregnancy and adverse outcomes in HIV-exposed uninfected infants and children using a trigger-based design.
    Williams PL; Hazra R; Van Dyke RB; Yildirim C; Crain MJ; Seage GR; Civitello L; Ellis A; Butler L; Rich K;
    AIDS; 2016 Jan; 30(1):133-44. PubMed ID: 26731758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.